The first book focusing specifically on frequent and frequently disabling side effects involving the skin, hair and nails in cancer patients
According to the World Health Organization, there are approximately thirty million people living with a diagnosis of cancer – the majority of whom will receive surgery, systemic therapy, and/or radiation, and who will suffer from dermatologic adverse events. Dermatologists and oncologists are only beginning to grapple with these events, which pose serious quality-of-life issues with so many patients, and will become more prevalent as survival rates improve, thanks in part to new cancer treatments and drug regimens.
Concentrating on a topic that has only been briefly touched upon by other texts, this book offers a focused perspective on the clinical presentation, underlying pathophysiologic mechanisms, and management of skin, hair, and nail conditions for oncologists, dermatologists, and allied practitioners.
Dermatologic Principles and Practice in Oncology: Conditions of the Skin, Hair, and Nails in Cancer Patients:
- Covers in detail the dermatologic adverse events of oncologic therapies, clinical presentations, and treatment recommendations
- Enables dermatologists and other practitioners to significantly improve the care of patients with cancer
- Addresses the dermatologic adverse events of cancer therapies used globally, of which a large number are found in developing countries
- Emphasizes prophylactic measures – based on treatments used and type of cancer – to prevent the appearance of adverse events
- Provides built-in discussions on patient education for practical counseling during therapies
- Offers rapid-reference sections on topical dermatology drugs
The first book to present dermatologic conditions in cancer patients and survivors in a uniform and in-depth manner, Dermatologic Principles and Practice in Oncology is ideal for oncologists, oncology nurses, and dermatologists who wish to take better care of those with adverse skin, hair, and nail conditions.
Table of Contents
List of Contributors, vii
Preface, x
Section 1 Dermatology and Oncology
1 Epidemiology and Burden of Disease, 3
Beth N. McLellan, Devika Patel and Mario E. Lacouture
2 The History of Supportive Oncodermatology, 17
Yevgeniy Balagula, Steven T. Rosen and Mario E. Lacouture
3 Structure and Function of the Integumentary System and the Dermatology Lexicon, 24
Emmy Graber and Amit Garg
4 Types of Dermatologic Reactions, 33
Raed O. Alhusayen, Sandra R. Knowles and Neil H. Shear
5 Grading Dermatologic Adverse Events in Clinical Trials Using CTCAE v4.0, 47
Alice Chen, Asha Acharya and Ann Setser
6 Psychosocial Issues in Oncology: Clinical Management of Psychosocial Distress, Health-Related Quality of Life, and Special Considerations in Dermatologic Oncology, 60
Lynne I. Wagner and David Cella
7 Dermatopathology, 69
Molly A. Hinshaw and James L. Troy
Section 2 Cancer-Related Dermatologic Disorders
8 Paraneoplastic, Inherited Cancer Syndrome, and Environmental Carcinogen-Related Dermatoses, 77
Cindy England Owen and Jeffrey P. Callen
Section 3 Dermatologic Conditions During Cancer Therapy
9 Oral Mucosal Complications of Cancer Therapy, 89
Stephen T. Sonis
10 Hair Disorders Associated with Anticancer Agents, 100
Caroline Yeager and Elise A. Olsen
11 Nail Abnormalities in Oncology Practice, 115
Robert Baran, Bernard Fouilloux and Caroline Robert
12 Pruritus, 122
Tejesh Patel and Gil Yosipovitch
13 Management Options for Hot Flashes in Cancer Patients, 131
Amanda R. Moraska and Charles L. Loprinzi
Section 4 Skin Toxicities to Chemotherapy
14 Alkylating Agents, 147
Elisabeth Livingstone, Lisa Zimmer, Larissa Leister and Dirk Schadendorf
15 Antimetabolite Reactions, 160
Emily Y. Chu and Heidi H. Kong
16 Topoisomerase-Interacting Agents, 170
Tomas Skacel, Roger von Moos and Reinhard Dummer
17 Epidermal Growth Factor Receptor Inhibitor Reactions, 184
Yevgeniy Balagula and Mario E. Lacouture
18 Small Molecule Multikinase Inhibitors, 196
Caroline Robert, Vincent Sibaud and Christine Mateus
19 Antimicrotubule Agents, 208
Claus Garbe
20 Histone Deacetylase Inhibitors, Proteasome Inhibitors, Demethylating Agents, Arsenicals, and Retinoids, 215
Najla Al-Dawsari, Shannon C. Trotter and Francine Foss
21 Miscellaneous Reactions, 224
Katharina C. Kaehler, Christine B. Boers-Doets, Mario E. Lacouture and Axel Hauschild
22 Skin Toxicities due to Biotherapy, 233
Kathryn T. Ciccolini, Katharina C. Kaehler, Mario E. Lacouture and Axel Hauschild
23 Monoclonal Antibodies, 241
Caroline Robert
24 Endocrine Agents, 248
Katherine Szyfelbein Masterpol, Maura Dickler and Mario E. Lacouture
25 Agents for the Management of Hematologic Reactions, 257
Mee-young Lee and Caroline C. Kim
26 Radiation-Induced Skin Reactions, 264
Rebecca K.S. Wong and Zahra Kassam
27 Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease, 281
Stephanie W. Hu and Jonathan Cotliar
28 Extravasation Reactions, 295
Seppo W. Langer
29 Topical Anticancer Therapies, 301
Patricia L. Myskowski
30 Life-threatening (Serious) Dermatologic Adverse Events, 310
Milan J. Anadkat
31 Dermatologic Infections, 319
Yevgeniy Balagula, Mario E. Lacouture and James I. Ito
Section 5 Late Cutaneous Events from Cancer Treatment
32 Late Dermatologic Conditions, 339
Jennifer Nam Choi
Section 6 Dermatologic Practice in Oncology
33 Management Algorithms for Dermatologic Adverse Events, 367
Alyx Rosen, Iris Amitay-Laish and Mario E. Lacouture
34 Dermatologic Therapeutics and Formulations, 384
Judy H. Borovicka, Jennifer R.S. Gordon, Ann Cameron Haley, Nicole E. Larsen and Dennis P. West
35 Dermatologic Techniques and Procedures, 401
Robert Eilers Jr., Kishwer S. Nehal and Erica H. Lee
36 Appearance-Related Concerns in the Cancer Patient, 410
Amy J. Derick
Index, 417
